Skip to main content

Site notifications

MMDR: TGA advisory committees reforms

Published

Related content

  • MMDR: Accessing unapproved products reforms

    Reforms relating to accessing unapproved products include modifications to the Special Access Scheme and Authorised Prescriber scheme to allow streamlined access to certain unapproved therapeutic products.
  • MMDR: Complementary medicine regulatory reforms

    The complementary medicine regulatory reforms include changes that will create a new approval pathway for listed complementary medicines and increase availability of information to support consumer decisions.
  • MMDR: Prescription medicines regulatory reforms

    The prescription medicines regulatory reforms include changes that will bring medicines to market sooner in Australia, while maintaining a robust framework for safety, quality and efficacy.